-
Early days, but a few dots are getting joined up at last. Hope it continues.
-
What a lovely, lovely day to be a CDY holder
Revenue guidance ....UP
http://www.asx.com.au/asxpdf/2015070...kh3dqhwkgq.pdf
Last edited by psychic; 09-07-2015 at 04:03 PM.
-
Hmmmm. Not bad for an under 25mil market cap.
1.05 mil for a quarter. This is half the full year guidance coming in the last quarter.
If not cashflow positive then must be close to it.
Share price reacting to near previous high and oppies at .033 - thats up 50% since early June.
Could be a fair bit of hair loss in China at the moment so sales may improve even further in the near future.
Suddenly its not as cold as it was.
Cheers
Miner
Last edited by Minerbarejet; 09-07-2015 at 07:40 PM.
-
Options were $0.009 at the begining if the week (I picked up 1/2 a million)
They are now $0.014 Over 50% in a week when world shares are very shaky.
There is still some incoming tide here I feel. (DYOR)
But very happy with progress so far.
-
Why would a small biotec company hold a worldwide conference call to update a few shareholders on progress and plans?
Thats what is happening this Tuesday at Cellmid.
Will be watching for a trading halt on Monday afternoon.
-
Originally Posted by Minerbarejet
Why would a small biotec company hold a worldwide conference call to update a few shareholders on progress and plans?
Thats what is happening this Tuesday at Cellmid.
Will be watching for a trading halt on Monday afternoon.
From the revenue guidance up-grade.
"Cellmid will be hosting a conference call to brief the market on its sales and
distribution outlook.
The senior executive team will be providing an update on significant increase in sales
and distribution for its evolis® and Advangen® branded hair growth products.
And will provide insights on how sales from the consumer health division increased
significantly during 4Q 2015, and what that means for future revenue.
in particular the recent increase in direct to customer sales, will also
comment on plans for the rest of Asia.
And report on some of the very
important research and development that underpins ongoing success.
The products work and sales are taking off. (my words)
GLTAH
-
Member
Shareholder 2yrs and user of evolis 3 months. Tried all the rest. This sh*t actually works. Sit tight for the ride.
-
Originally Posted by cammo
Shareholder 2yrs and user of evolis 3 months. Tried all the rest. This sh*t actually works. Sit tight for the ride.
Good on you cammo. Nice to get confirmation from a user.
-
Member
-
Solid end to the day at .036, new 52 week high. Clarification of sales tomorrow via conference call should be pretty revealing.
CEO Maria Halasz is known to understate and overdeliver with something out of left field on occasion. Any if this tomorrow should give the SP another bunt in the right direction.
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks